The classic website will no longer be available as of June 25, 2024. Please use the modernized ClinicalTrials.gov.
Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT04837859
Brief Title: Phase II Trial of Individualized Immunotherapy in Early-Stage Unfavorable Classical Hodgkin Lymphoma (INDIE)

First Submitted : April 6, 2021
First Submitted that Met QC Criteria : April 6, 2021
First Posted : April 8, 2021

Last Update Submitted that Met QC Criteria : September 12, 2023
Last Update Posted : September 14, 2023